Annual Cash & Cash Equivalents
$25.44 M
-$358.00 K-1.39%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual cash & cash equivalents is $25.44 million, with the most recent change of -$358.00 thousand (-1.39%) on December 31, 2023.
- During the last 3 years, EIGR annual cash & cash equivalents has fallen by -$3.42 million (-11.86%).
- EIGR annual cash & cash equivalents is now -58.47% below its all-time high of $61.26 million, reached on December 31, 2018.
Performance
EIGR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$25.44 M
-$2.06 M-7.49%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly cash and cash equivalents is $25.44 million, with the most recent change of -$2.06 million (-7.49%) on December 31, 2023.
- Over the past year, EIGR quarterly cash and cash equivalents has dropped by -$358.00 thousand (-1.39%).
- EIGR quarterly cash and cash equivalents is now -76.53% below its all-time high of $108.41 million, reached on March 31, 2021.
Performance
EIGR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
EIGR Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.4% | -1.4% |
| 3 y3 years | -11.9% | -11.9% |
| 5 y5 years | -58.5% | -58.5% |
EIGR Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.4% | +14.5% | -45.4% | +67.6% |
| 5 y | 5-year | -35.4% | +14.5% | -76.5% | +67.6% |
| alltime | all time | -58.5% | +5335.9% | -76.5% | +221.9% |
Eiger BioPharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $25.44 M(-1.4%) | $25.44 M(-7.5%) |
| Sep 2023 | - | $27.50 M(+19.7%) |
| Jun 2023 | - | $22.98 M(+51.4%) |
| Mar 2023 | - | $15.18 M(-41.2%) |
| Dec 2022 | $25.80 M(+16.1%) | $25.80 M(-1.9%) |
| Sep 2022 | - | $26.31 M(-28.1%) |
| Jun 2022 | - | $36.57 M(-21.5%) |
| Mar 2022 | - | $46.56 M(+109.5%) |
| Dec 2021 | $22.22 M(-23.0%) | $22.22 M(-54.9%) |
| Sep 2021 | - | $49.26 M(-24.3%) |
| Jun 2021 | - | $65.06 M(-40.0%) |
| Mar 2021 | - | $108.41 M(+275.6%) |
| Dec 2020 | $28.86 M(-26.7%) | $28.86 M(-44.5%) |
| Sep 2020 | - | $51.99 M(-17.2%) |
| Jun 2020 | - | $62.81 M(+177.6%) |
| Mar 2020 | - | $22.63 M(-42.5%) |
| Dec 2019 | $39.37 M(-35.7%) | $39.37 M(+102.9%) |
| Sep 2019 | - | $19.41 M(-66.8%) |
| Jun 2019 | - | $58.42 M(-7.9%) |
| Mar 2019 | - | $63.41 M(+3.5%) |
| Dec 2018 | $61.26 M | $61.26 M(+261.9%) |
| Sep 2018 | - | $16.93 M(-49.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $33.32 M(+0.2%) |
| Mar 2018 | - | $33.25 M(+3.8%) |
| Dec 2017 | $32.03 M(+15.4%) | $32.03 M(+145.0%) |
| Sep 2017 | - | $13.08 M(+16.8%) |
| Jun 2017 | - | $11.20 M(-22.5%) |
| Mar 2017 | - | $14.45 M(-47.9%) |
| Dec 2016 | $27.76 M(-15.3%) | $27.76 M(-50.7%) |
| Sep 2016 | - | $56.29 M(+24.0%) |
| Jun 2016 | - | $45.40 M(-25.8%) |
| Mar 2016 | - | $61.20 M(+86.7%) |
| Dec 2015 | $32.78 M(+127.1%) | $32.78 M(-11.6%) |
| Sep 2015 | - | $37.09 M(-25.9%) |
| Jun 2015 | - | $50.04 M(+0.0%) |
| Mar 2015 | - | $50.02 M(+246.5%) |
| Dec 2014 | $14.44 M(+82.7%) | $14.44 M(+0.5%) |
| Sep 2014 | - | $14.37 M(+7.4%) |
| Jun 2014 | - | $13.37 M(-75.2%) |
| Mar 2014 | - | $53.88 M(+581.7%) |
| Dec 2013 | $7.90 M(-42.9%) | $7.90 M(-20.6%) |
| Sep 2013 | - | $9.96 M(+19.7%) |
| Jun 2013 | - | $8.32 M |
| Dec 2012 | $13.84 M(+2857.5%) | - |
| Dec 2011 | $468.00 K | - |
FAQ
- What is Eiger BioPharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Eiger BioPharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Eiger BioPharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of EIGR is $25.44 M
What is the all time high annual cash & cash equivalents for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual cash & cash equivalents is $61.26 M
What is Eiger BioPharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, EIGR annual cash & cash equivalents has changed by -$358.00 K (-1.39%)
What is Eiger BioPharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of EIGR is $25.44 M
What is the all time high quarterly cash and cash equivalents for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly cash and cash equivalents is $108.41 M
What is Eiger BioPharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, EIGR quarterly cash and cash equivalents has changed by -$358.00 K (-1.39%)